Citation Impact
Citing Papers
Multi-Institutional Randomized Phase II Trial of Gefitinib for Previously Treated Patients With Advanced Non–Small-Cell Lung Cancer
2003 Standout
Increased Mortality, Postoperative Morbidity, and Cost After Red Blood Cell Transfusion in Patients Having Cardiac Surgery
2007 Standout
Sulfur [ 18 F]Fluoride Exchange Click Chemistry Enabled Ultrafast Late-Stage Radiosynthesis
2021 StandoutNobel
Phase III Study Comparing Cisplatin Plus Gemcitabine With Cisplatin Plus Pemetrexed in Chemotherapy-Naive Patients With Advanced-Stage Non–Small-Cell Lung Cancer
2008 Standout
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
Prevalence and Risk of Cancer of Focal Thyroid Incidentaloma Identified by18F-Fluorodeoxyglucose Positron Emission Tomography for Metastasis Evaluation and Cancer Screening in Healthy Subjects
2003
Artificially engineered magnetic nanoparticles for ultra-sensitive molecular imaging
2006 Standout
Levels of hypoxia‐inducible factor‐1α independently predict prognosis in patients with lymph node negative breast carcinoma
2003 StandoutNobel
Why do cancers have high aerobic glycolysis?
2004 Standout
PET in oncology: Will it replace the other modalities?
1997
Duration of Red-Cell Storage and Complications after Cardiac Surgery
2008 Standout
Nasopharyngeal carcinoma
2005 Standout
Evaluation of fluorine-18-fluorodeoxyglucose whole body positron emission tomography imaging in the staging of lung cancer
1999
Can positron emission tomography (PET) be used to detect subclinical response to cancer therapy?
1995
Monitoring response to therapy in cancer using [ 18 F]-2-fluoro-2-deoxy- d -glucose and positron emission tomography: an overview of different analytical methods
2000
Parkinson's disease
2021 Standout
Cerebral blood flow findings in moyamoya disease in adults
2009
The role of porphyrin chemistry in tumor imaging and photodynamic therapy
2010 Standout
The Blood-Brain Barrier in Health and Chronic Neurodegenerative Disorders
2008 Standout
Vascular dementia
2015 Standout
FDG-PET scan in potentially operable non-small cell lung cancer: do anatometabolic PET-CT fusion images improve the localisation of regional lymph node metastases?
1998
PET, CT, and MRI with Combidex for mediastinal staging in non-small cell lung carcinoma
1999
Microglia-mediated neurotoxicity: uncovering the molecular mechanisms
2006 Standout
Gefitinib or Carboplatin–Paclitaxel in Pulmonary Adenocarcinoma
2009 Standout
The Thyroid Nodule
2004 Standout
Alterations in the BOLD fMRI signal with ageing and disease: a challenge for neuroimaging
2003
The impact of 18F-fluoro-2-deoxy-d-glucose positron emission tomography (FDG-PET) lymph node staging on the radiation treatment volumes in patients with non-small cell lung cancer
2000
Acetazolamide Vasoreactivity in Vascular Dementia: A Positron Emission Tomographic Study
1999
Cerebral circulation and oxygen metabolism in childhood moyamoya disease: a perioperative positron emission tomography study
1994
FDG–PET in staging and restaging non-small cell lung cancer after neoadjuvant chemoradiotherapy: correlation with histopathology
2002
Cushing's syndrome
2015 Standout
Exercise Standards for Testing and Training
2013 Standout
Apoptosis Decision Cascades and Neuronal Degeneration in Alzheimer’s Disease
1998
Cerebral hypoxia after hyperventilation causes ?re-build-up? phenomenon and TIA in childhood moyamoya disease
1996
The Science of Stroke: Mechanisms in Search of Treatments
2010 Standout
Introduction of Fluorine and Fluorine‐Containing Functional Groups
2013 Standout
Value of FDG PET Imaging in the Management of Patients With Thyroid, Neuroendocrine, and Neural Crest Tumors
2004
Cerebral hemodynamics and metabolism in adult moyamoya disease: Comparison of angiographic collateral circulation
2004
Cerebral hemodynamics and ?re-build-up? phenomenon on electroencephalogram in children with moyamoya disease
1995
Metabolic monitoring of breast cancer chemohormonotherapy using positron emission tomography: initial evaluation.
1993
Abnormal functional connectivity in patients with vascular cognitive impairment, no dementia: A resting-state functional magnetic resonance imaging study
2011
Quantification of myocardial blood flow and flow reserve in children with a history of kawasaki disease and normal coronary arteries using positron emission tomography
1996
Invited. MRI and MR angiography in moyamoya disease
1998
Erlotinib in Previously Treated Non–Small-Cell Lung Cancer
2005 Standout
Vascular aspects of multiple sclerosis
2011
Regulation of cancer cell metabolism
2011 Standout
Parkinson's disease
2015 Standout
The impact of fluorodeoxyglucose F 18 positron-emission tomography on the surgical staging of non–small cell lung cancer
2002
Cerebral blood flow and metabolism in patients with silent brain infarction: occult misery perfusion in the cerebral cortex
1998
Glial and neuronal control of brain blood flow
2010 StandoutNature
Paracrine Induction of HIF by Glutamate in Breast Cancer: EglN1 Senses Cysteine
2016 StandoutNobel
Nasopharyngeal carcinoma
2015 Standout
Replicating Huntington's disease phenotype in experimental animals
1999
Exercise capacity and incidence of myocardial perfusion defects after Kawasaki disease in children and adolescents
1995
Slower progression of Parkinson's disease with ropinirole versus levodopa: The REAL‐PET study
2003
Lymph node staging in non-small-cell lung cancer with FDG-PET scan: a prospective study on 690 lymph node stations from 68 patients.
1998
Migraine — Current Understanding and Treatment
2002 Standout
Review: Cerebral microvascular pathology in ageing and neurodegeneration
2010
Diagnostic Accuracy of 18F-Fluorodeoxyglucose Positron Emission Tomography in the Follow-Up of Papillary or Follicular Thyroid Cancer
2001
Positron emission tomography in the diagnosis and staging of lung cancer: a systematic, quantitative review
2001
Ultrasound Tissue Characterization of the Myocardium in Patients After Kawasaki Disease
2010
Preoperative and postoperative mapping of cerebrovascular reactivity in moyamoya disease by using blood oxygen level—dependent magnetic resonance imaging
2005
Fluorine-18-fluorodeoxyglucose positron emission tomography in the preoperative assessment of thyroid nodules in an endemic goiter area
2003
Do Kawasaki disease patients without coronary artery abnormalities need a long‐term follow‐up? A myocardial single‐photon emission computed tomography pilot study
2009
Voxel-Based Mapping of Brain Hypometabolism in Permanent Amnesia with PET
2001
Pathological features of cerebral cortical capillaries are doubled in Alzheimer's disease and Parkinson's disease
2000
Positron emission tomography with CT in the evaluation of non‐small cell lung cancer in populations with a high prevalence of tuberculosis
2006
Parkinson's Disease
1998 Standout
Neuroblastoma
2007 Standout
Mediastinal Lymph Node Staging With FDG-PET Scan in Patients With Potentially Operable Non-small Cell Lung Cancer
1997
Moyamoya disease: current concepts and future perspectives
2008 Standout
CT and 18F-deoxyglucose (FDG) image fusion for optimization of conformal radiotherapy of lung cancers
2001
Tomographic imaging using the nonlinear response of magnetic particles
2005 StandoutNature
Surgery for Seizures
1996 Standout
The Relative Contributions of MRI, SPECT, and PET Imaging in Epilepsy
1994
Accuracy and Clinical Impact of Mediastinal Lymph Node Staging with FDG–PET Imaging in Potentially Resectable Lung Cancer
2000
Contributions of Positron Emission Tomography to elucidating the pathogenesis of Idiopathic Parkinsonism and Dopa Responsive Dystonia
1997
Imaging biomarkers in Parkinson's disease
2011
Reduced cerebral blood flow in white matter in ischaemic leukoaraiosis demonstrated using quantitative exogenous contrast based perfusion MRI
2000
18‐Fluoro‐2‐deoxyglucose positron emission tomography in detecting residual/recurrent nasopharyngeal carcinomas and comparison with magnetic resonance imaging
2003
18-F-fluorodeoxyglucose-positron emission tomography as a new approach to detect lymphomatous bone marrow.
1998
The Pathobiology of Vascular Dementia
2013 Standout
Recent experience with Moyamoya disease in Turkey
2000
Preparation of fluorine-18 labelled sugars and derivatives and their application as tracer for positron-emission-tomography
2000
Regional cerebral hemodynamics in childhood moyamoya disease
1995
Comparison of 201Tl SPET and treadmill exercise testing in patients with Kawasaki disease
2000
Staging of non-small cell lung cancer: consensus, controversies and challenges
2001
F-18 FDG Uptake in Breast Infection and Inflammation
2000
Subcortical ischaemic vascular dementia
2002 Standout
High-field magnetic resonance imaging in patients with moyamoya disease
2001
Sumatriptan in clinical practice
1996
Multiple burr-hole operation for adult moyamoya disease
1996
Metastases from Non-Small Cell Lung Cancer: Mediastinal Staging in the 1990s—Meta-analytic Comparison Of PET and CT
1999
Value of positron emission tomography for lung cancer staging
2002
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association
2017 Standout
Moyamoya Disease and Moyamoya Syndrome
2009 Standout
Natural history of Moyamoya disease: comparison of activity of daily living in surgery and non surgery groups
1997
Symptoms, Vascular Risk Factors and Blood-Brain Barrier Function in Relation to CT White-Matter Changes in Dementia
2000
Potential use of FDG-PET scan after induction chemotherapy in surgically staged IIIa–N2 non-small-cell lung cancer: A prospective pilot study
1998
Silicosis
2012 Standout
Comparison of positron emission tomography study results of cerebral hemodynamics in patients with bleeding- and ischemic-type moyamoya disease
1998
Histological Aggressiveness of Fluorodeoxyglucose Positron-Emission Tomogram (FDG-PET)-Detected Incidental Thyroid Carcinomas
2007
Cerebral vasomotor reactivity and cerebral white matter lesions in the elderly
1999
Fluorine in medicinal chemistry
2007 Standout
Biologic Correlates of 18Fluorodeoxyglucose Uptake in Human Breast Cancer Measured by Positron Emission Tomography
2002 StandoutNobel
Positron Emission Tomography Scanning: Current and Future Applications
2002
[18F]-2-Fluoro-2-Deoxy-d-Glucose Positron Emission Tomography Localizes Residual Thyroid Cancer in Patients with Negative Diagnostic 131I Whole Body Scans and Elevated Serum Thyroglobulin Levels
1999
Prognostic Value of Dipyridamole-Thallium Myocardial Scintigraphy in Patients With Kawasaki Disease
1998
Fresh Blood and Aged Stored Blood Are Equally Efficacious in Immediately Reversing Anemia-induced Brain Oxygenation Deficits in Humans
2006
18F-fluorodeoxyglucose positron emission tomography and the prognosis of patients with pancreatic adenocarcinoma
1997
Stereospecific fluorination of 1,3,5-tri-O-benzoyl-α-d-ribofuranose-2-sulfonate esters: preparation of a versatile intermediate for synthesis of 2′-[]-fluoro-arabinonucleosides
2000
Optimal interpretation of FDG PET in the diagnosis, staging and management of pancreatic carcinoma.
1999
Hypoperfusion of the Cerebral White Matter in Multiple Sclerosis: Possible Mechanisms and Pathophysiological Significance
2008
Early predictors of mortality in parkinsonism and Parkinson disease
2018
Periventricular white matter lucency and cerebral blood flow autoregulation in hypertensive patients.
1994
18F-Fluorodeoxyglucose Positron Emission Tomography Does Not Predict Malignancy in Thyroid Nodules Cytologically Diagnosed as Follicular Neoplasm
2007
Preoperative and Postoperative Evaluation of Cerebral Perfusion and Vasodilatory Capacity With 99m Tc-HMPAO SPECT and Acetazolamide in Childhood Moyamoya Disease
1996
Positron Emission Tomography Using [18F]-Fluorodeoxy-d -Glucose to Predict the Pathologic Response of Breast Cancer to Primary Chemotherapy
2000
Noninvasive grading of musculoskeletal tumors using PET.
1991
(18)F-FDG PET provides high-impact and powerful prognostic stratification in staging newly diagnosed non-small cell lung cancer.
2001
Breast Imaging With Positron Emission Tomography and Fluorine-18 Fluorodeoxyglucose: Use and Limitations
2000
Mitochondrial Reactive Oxygen Species (ROS) and ROS-Induced ROS Release
2014 Standout
Hippocampal and cortical atrophy predict dementia in subcortical ischemic vascular disease
2000
Default-mode network activity distinguishes Alzheimer's disease from healthy aging: Evidence from functional MRI
2004 Standout
Patterns of cerebral blood flow reduction in patients with ischemic leukoaraiosis
2002
Cerebral hemodynamics in Moyamoya disease: correlation between perfusion-weighted MR imaging and cerebral angiography.
2006
Positron emission tomography in non-Hodgkin's lymphoma: assessment of chemotherapy with fluorodeoxyglucose.
1998
Alzheimer's Disease: Genes, Proteins, and Therapy
2001 Standout
Lessons from a Mouse Model Characterizing Features of Vascular Cognitive Impairment with White Matter Changes
2011
Cerebral Ischemic Complications Following Intracranial Bleeding in Patients With Moyamoya Disease. Three Case Reports.
2001
Radiohalogen incorporation into organic systems
2002
Long-term Consequences of Kawasaki Disease
1996 Standout
Biologic Correlates of 18Fluorodeoxyglucose Uptake in Human Breast Cancer Measured by Positron Emission Tomography
2002
Recommendations for Initial Evaluation, Staging, and Response Assessment of Hodgkin and Non-Hodgkin Lymphoma: The Lugano Classification
2014 Standout
Role of 18F-Fluorodeoxyglucose Positron Emission Tomography in Preoperative Assessment of Cytologically Indeterminate Thyroid Nodules
2007
Pathogenesis of Leukoaraiosis
1997 Standout
Focal thyroid lesions incidentally identified by integrated 18F-FDG PET/CT: clinical significance and improved characterization.
2006
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease
2004 Standout
18F-FDG PET reduces unnecessary hemithyroidectomies for thyroid nodules with inconclusive cytologic results.
2006
MRI predictors of cognition in subcortical ischemic vascular disease and Alzheimer’s disease
2001
Rational Approach to Treatment of Moyamoya Disease in Childhood
2000
Clinical Impact of 18F Fluorodeoxyglucose Positron Emission Tomography in Patients With Non–Small-Cell Lung Cancer: A Prospective Study
2001
Preoperative FDG‐PET imaging to assess the malignant potential of follicular neoplasms of the thyroid
2008
Report of an International Workshop to Standardize Response Criteria for Non-Hodgkin's Lymphomas
1999 Standout
American Society of Clinical Oncology Treatment of Unresectable Non–Small-Cell Lung Cancer Guideline: Update 2003
2003 Standout
Detection of Lymphoma in Bone Marrow by Whole-Body Positron Emission Tomography
1998
Works of Y Ichiya being referenced
FDG-PET in infectious lesions: The detection and assessment of lesion activity
1996
Synthesis and biodistribution of a fluorine-18 labeled analogue of d-talose: 2-deoxy-2-[18F]fluoro-d-talose
1992
Differences in the reduced 18F-Dopa uptakes of the caudate and the putamen in Parkinson's disease: correlations with the three main symptoms
1996
Discordance between thallium-201 scintigraphy and coronary angiography in patients with kawasaki disease: Myocardial ischemia with normal coronary angiogram
1993
An evaulation of FDG-PET in the detection and differentiation of thyroid tumours
1997
High [18F]FDG Uptake in Primary Cerebral Lymphoma
1988
A clinical evaluation of FDG-PET to assess the response in radiation therapy for bronchogenic carcinoma
1996
High [18F]-Fluorodeoxyglucose Uptake in Abdominal Abscesses
1989
Cerebral glucose metabolism and striatal 18F-Dopa uptake by PET in cases of chorea with or without dementia
1993
Radiosynthesis, rodent biodistribution, and metabolism of 1-deoxy-1-[18F]fluoro-d-fructose
1995
Positron Emission Tomography in Partial Epilepsy and Its Relation to Clinical and EEG Findings
1988
Cerebral hemodynamics and metabolism in Moyamoya disease—a positron emission tomography study
1997
Cerebral blood flow and vascular response to hypercapnia in hypertensive patients with leukoaraiosis
1996
The usefulness of FDG positron emission tomography for the detection of mediastinal lymph node metastases in patients with non-small cell lung cancer: a comparative study with X-ray computed tomography
1996
Regional cerebral glucose metabolism in patients with Parkinson’s disease with or without dementia
1992
Positron emission tomographic (PET) studies in dementia
1993
Cerebral hemodynamic change in the child and the adult with moyamoya disease.
1990
Cerebral Blood Flow and Metabolism in an Amnestic Patient with Left Thalamic Infarction. A Positron Emission Tomographic Study.
1991
Leukoaraiosis and dementia in hypertensive patients.
1992
Cerebrovascular responsiveness to hypercapnia in Alzheimer's dementia and vascular dementia of the Binswanger type.
1992
CBF and oxygen metabolism in hemodialysis patients: effects of anemia correction with recombinant human EPO
1992
Response to Hypercapnia in Moyamoya Disease
1997
Cerebral blood flow and oxygen metabolism in patients with vascular dementia of the Binswanger type.
1990
Synthesis and in vivo evaluation of a new fluorine‐18 labeled dopamine D2 radioligand synthesis with benzofuran benzamide skeleton
1993
Assessment of response to cancer therapy using fluorine-18-fluorodeoxyglucose and positron emission tomography.
1991
Cerebral blood flow and metabolism in normotensive and hypertensive patients with transient neurologic deficits.
1990
Striatal blood flow, glucose metabolism and 18F-dopa uptake: difference in Parkinson's disease and atypical parkinsonism.
1991
Time Dependency of the Acetazolamide Effect on Cerebral Hemodynamics in Patients With Chronic Occlusive Cerebral Arteries
1995
Regional cerebral blood flow and metabolism in patients with transient global amnesia: a positron emission tomography study.
1989